Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19 - a podcast by JAMA Network

from 2021-10-07T15:00

:: ::

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

Further episodes of Coronavirus (COVID-19) Q&A

Further podcasts by JAMA Network

Website of JAMA Network